GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS (IST:GENIL) » Definitions » Beneish M-Score

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Beneish M-Score : -1.78 (As of May. 22, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.78 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Beneish M-Score or its related term are showing as below:

IST:GENIL' s Beneish M-Score Range Over the Past 10 Years
Min: -1.78   Med: -1.76   Max: 0.51
Current: -1.78

During the past 6 years, the highest Beneish M-Score of Gen Ilac Veglik Urunlerinayi ve Ticaret AS was 0.51. The lowest was -1.78. And the median was -1.76.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Beneish M-Score Historical Data

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Beneish M-Score Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - - -1.76 0.51 -1.78

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
Dec18 Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 -0.76 -1.55 0.14 -1.78

Competitive Comparison of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Beneish M-Score falls into.



Gen Ilac Veglik Urunlerinayi ve Ticaret AS Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Gen Ilac Veglik Urunlerinayi ve Ticaret AS for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 2.2023+0.528 * 0.8139+0.404 * 1.1858+0.892 * 0.7662+0.115 * 0.8113
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.3263+4.679 * 0.035947-0.327 * 1.8145
=-1.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was ₺1,570 Mil.
Revenue was 3727.913 + 2356.464 + 1125.118 + 942.124 = ₺8,152 Mil.
Gross Profit was 672.61 + 480.409 + 344.003 + 302.43 = ₺1,799 Mil.
Total Current Assets was ₺3,952 Mil.
Total Assets was ₺7,712 Mil.
Property, Plant and Equipment(Net PPE) was ₺2,439 Mil.
Depreciation, Depletion and Amortization(DDA) was ₺266 Mil.
Selling, General, & Admin. Expense(SGA) was ₺486 Mil.
Total Current Liabilities was ₺2,713 Mil.
Long-Term Debt & Capital Lease Obligation was ₺64 Mil.
Net Income was -132.158 + 316.652 + 165.823 + 104.265 = ₺455 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₺0 Mil.
Cash Flow from Operations was -178.881 + 301.642 + 232.027 + -177.44 = ₺177 Mil.
Total Receivables was ₺931 Mil.
Revenue was 6347.043 + 1324.25 + 1736.274 + 1231.772 = ₺10,639 Mil.
Gross Profit was 1078.832 + 292.218 + 285.357 + 255.04 = ₺1,911 Mil.
Total Current Assets was ₺3,193 Mil.
Total Assets was ₺6,322 Mil.
Property, Plant and Equipment(Net PPE) was ₺2,216 Mil.
Depreciation, Depletion and Amortization(DDA) was ₺192 Mil.
Selling, General, & Admin. Expense(SGA) was ₺479 Mil.
Total Current Liabilities was ₺1,123 Mil.
Long-Term Debt & Capital Lease Obligation was ₺132 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1570.275 / 8151.619) / (930.631 / 10639.339)
=0.192634 / 0.087471
=2.2023

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1911.447 / 10639.339) / (1799.452 / 8151.619)
=0.179658 / 0.220748
=0.8139

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3952.337 + 2439.341) / 7712.312) / (1 - (3193.196 + 2216.226) / 6322.446)
=0.171237 / 0.14441
=1.1858

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=8151.619 / 10639.339
=0.7662

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(192.081 / (192.081 + 2216.226)) / (265.967 / (265.967 + 2439.341))
=0.079758 / 0.098313
=0.8113

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(486.492 / 8151.619) / (478.751 / 10639.339)
=0.05968 / 0.044998
=1.3263

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((64.364 + 2712.949) / 7712.312) / ((132.039 + 1122.751) / 6322.446)
=0.360114 / 0.198466
=1.8145

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(454.582 - 0 - 177.348) / 7712.312
=0.035947

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS has a M-score of -1.78 suggests that the company is unlikely to be a manipulator.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Business Description

Traded in Other Exchanges
N/A
Address
Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Headlines

No Headlines